Dr Reddys Laboratories Share Price Today - Live Blog for September 22, 2025

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.05% gain, with the share price now at ₹1,303.45. Notably, the stock's PE ratio stands at 19.4300, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.16% uptick in its share price. As a result, it's now actively trading at ₹1,303.65 per share, making it an attractive option for investors.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.18% drop, and it's now trading at ₹1,298.30 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd experienced a -0.18% dip in its share price and is currently trading at ₹1,298.30. The stock has a PE ratio of 19.4300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.31% drop, and it's now trading at ₹1,300.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd's share price has fallen by -0.21%, a situation worth noting. At present, the stock is trading at ₹1,302.70. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 19.4300, while the industry PE ratio is 35.7722.

After a -0.04% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,307.05. The stock has a PE ratio of 19.4300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.08% in its share price, and it currently trades at ₹1,306.70 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd witnessed a substantial 0.19% increase in its share price and is currently trading at ₹1,307.75. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd experienced a -0.12% dip in its share price and is currently trading at ₹1,312.65. The stock has a PE ratio of 19.4300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.12% in its share price, and it currently trades at ₹1,312.65 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.06% dip in its share price and is currently trading at ₹1,313.00. The stock has a PE ratio of 19.4300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd stock price decreased by -0.06%, with the current market value at ₹1,313.00 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The share price of Dr Reddys Laboratories Ltd plunged by -0.06%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,313.00, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd witnessed a -0.06% decrease in its share price, and it is currently trading at ₹1,313.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.4300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd witnessed a notable 0.01% surge in its share price and is presently trading at ₹1,313.10, captivating the attention of market participants.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.15%, and as of now, it's trading at ₹1,313.00 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd's stock has surged by 0.01%, and it is currently trading at ₹1,312.50. Additionally, the stock maintains a PE ratio of 19.4300, while the industry PE is 35.7722.

Dr Reddys Laboratories Ltd stock price decreased by -0.13%, with the current market value at ₹1,311.95 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Dr Reddys Laboratories Ltd suffered a -0.13% decline, and it currently trades at ₹1,311.95 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

With a -0.13% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,311.95. Investors should examine the factors driving this decline. The stock's PE ratio is 19.4300, whereas the industry PE ratio stands at 35.7722.

Dr Reddys Laboratories Ltd witnessed a -0.04% decrease in its share price, and it is currently trading at ₹1,313.50. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.4300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd stock price decreased by -0.03%, with the current market value at ₹1,314.30 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd witnessed a substantial 0.19% increase in its share price and is currently trading at ₹1,314.65. This remarkable performance has caught the eye of investors.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.08% increase. Presently, it is actively trading at ₹1,312.20.

Dr Reddys Laboratories Ltd shares experienced a -0.08% reduction, with the current market price at ₹1,311.95. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd shares experienced a -0.44% reduction, with the current market price at ₹1,309.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd observed a remarkable 0.21% surge in its share price and is presently trading at ₹1,314.00. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd experienced a -0.05% downturn in its share price, and it's currently trading at ₹1,322.00. This situation is generating interest among value investors who are evaluating the stock's potential.